Research Focus

Former Employee. Molecular Pharmacology and Therapeutics

Recent additions – View all

1. Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers

   Journal Article

   Kensler, T. W.; He, X.; Otieno, M.; Egner, P. A.; Jacobson, L. P.; Chen, B.; Wang, J. S.; Zhu, Y. R.; Zhang, B. C.; Wang, J. B.; more...
   Cancer Epidemiology Biomarkers and Prevention (1998)

   Fulltext@MSK | Save
2. Oltipraz chemoprevention trial in Qidong, Jiangsu province, People's Republic of China

   Journal Article

   Zhang, B. C.; Zhu, Y. R.; Wang, J. B.; Wu, Y.; Zhang, Q. N.; Qian, G. S.; Kuang, S. Y.; Li, Y. F.; Fang, X.; Yu, L. Y.; more...
   Journal of Cellular Biochemistry (1997)

   Fulltext@MSK | Save
3. Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes

   Journal Article

   Jacobson, L. P.; Zhang, B. C.; Zhu, Y. R.; Wang, J. B.; Wu, Y.; Zhang, Q. N.; Yu, L. Y.; Qian, G. S.; Kuang, S. Y.; Li, Y. F.; more...
   Cancer Epidemiology Biomarkers and Prevention (1997)

   Fulltext@MSK | Save